Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 20 phantom stock units through the company's Supplemental Savings Plan on April 15, 2024.

Summary

• On April 15, 2024, Albert Bourla, the Chairman & CEO of Pfizer Inc., acquired 20 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $25.91.
• Following the transaction, Bourla directly owns 659,636 shares of Pfizer common stock.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The acquisition of phantom stock units is a moderately positive signal, suggesting confidence from the CEO, but it's a routine transaction.

Positives

• The acquisition of phantom stock units by the CEO could be interpreted as a sign of confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements, but the acquisition of phantom stock units suggests a continued alignment of the CEO's interests with the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of phantom stock units is a common form of executive compensation, aligning management's interests with shareholder value.

Stakeholder Impact

• The acquisition of phantom stock units by the CEO aligns his interests with those of shareholders, potentially encouraging decisions that increase shareholder value.

Key Dates